Araştırma Makalesi

Clinical and prognostic factors in children with dilated cardiomyopathy

Cilt: 14 Sayı: 4 1 Ekim 2021
Ayça Koca Yozgat *, Selmin Karademir
PDF İndir
TR EN

Clinical and prognostic factors in children with dilated cardiomyopathy

Öz

Purpose: Dilated cardiomyopathy is characterized by impaired myocardial contractility and cardiac dilatation. Most cases in children are idiopathic despite diagnostic developments. In this study, we aimed to review children with dilated cardiomyopathy and attempt to determine the prognostic factors. Materials and Methods: A total of 59 children with a diagnosis of dilated cardiomyopathy were evaluated retrospectively between January 2005 to January 2013. The age of onset of symptoms, gender, parental consanguinity, electrocardiography findings, presence of cardiomegaly in the telecardiograpy, left ventricular ejection fraction and shortening fraction on prognosis were evaluated. Results: The mean age of patients was 49.2 ± 59.2 months and the male/female ratio was 1.03/1. Heart failure symptoms and signs were the most common cause of admission. The most common electrocardiographic finding was left ventricular hypertrophy in 32.2% and cardiomegaly was observed on telecardiography in 77.8%. The left ventricular ejection and shortening fraction of patients’ were 38.4± 14.5% and 18.8± 8.4% at the time of the diagnosis and 51± 18.6% and 26.8± 11.6% at the end of the follow-up, respectively. The mean follow-up period was 27.5± 27.7 months and the mortality rate was 42.4%. The main factors affecting prognosis have been found as detection of electrocardiographic changes, cardiomegaly, and lower left ventricular ejection fraction at the time of the diagnosis. Conclusion: Dilated cardiomyopathy remains a challenging disease and the prognosis is poor. In our study, the most important prognostic markers affecting survival were determined by the presence of electrocardiographic changes, cardiomegaly, and a reduced ejection fraction.

Anahtar Kelimeler

Children, dilated cardiomyopathy, prognostic factors

Kaynakça

  1. 1. Nugent, A.W., P.E. Daubeney, P. Chondros, et al., The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med, 2003. 348(17): p. 1639-46. DOI: 10.1056/NEJMoa021737.
  2. 2. Richardson, P., W. McKenna, M. Bristow, et al., Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation, 1996. 93(5): p. 841-2. DOI: 10.1161/01.cir.93.5.841.
  3. 3. Lipshultz, S.E., L.A. Sleeper, J.A. Towbin, et al., The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med, 2003. 348(17): p. 1647-55. DOI: 10.1056/NEJMoa021715.
  4. 4. Cox, G.F., Diagnostic Approaches to Pediatric Cardiomyopathy of Metabolic Genetic Etiologies and Their Relation to Therapy. Prog Pediatr Cardiol, 2007. 24(1): p. 15-25. DOI: 10.1016/j.ppedcard.2007.08.013.
  5. 5. Towbin, J.A., A.M. Lowe, S.D. Colan, et al., Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA, 2006. 296(15): p. 1867-76. DOI: 10.1001/jama.296.15.1867.
  6. 6. Daubeney, P.E., A.W. Nugent, P. Chondros, et al., Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation, 2006. 114(24): p. 2671-8. DOI: 10.1161/CIRCULATIONAHA.106.635128.
  7. 7. Maron, B.J., J.A. Towbin, G. Thiene, et al., Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation, 2006. 113(14): p. 1807-16. DOI: 10.1161/CIRCULATIONAHA.106.174287.
  8. 8. Nandi, D. and J.W. Rossano, Epidemiology and cost of heart failure in children. Cardiol Young, 2015. 25(8): p. 1460-8. DOI: 10.1017/S1047951115002280.
  9. 9. Puggia, I., M. Merlo, G. Barbati, et al., Natural History of Dilated Cardiomyopathy in Children. J Am Heart Assoc, 2016. 5(7). DOI: 10.1161/JAHA.116.003450.
  10. 10. Dec, G.W., Jr., I.F. Palacios, J.T. Fallon, et al., Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med, 1985. 312(14): p. 885-90. DOI: 10.1056/NEJM198504043121404.

Kaynak Göster

APA
Koca Yozgat, A., & Karademir, S. (2021). Clinical and prognostic factors in children with dilated cardiomyopathy. Pamukkale Medical Journal, 14(4), 828-834. https://doi.org/10.31362/patd.843176
AMA
1.Koca Yozgat A, Karademir S. Clinical and prognostic factors in children with dilated cardiomyopathy. Pam Tıp Derg. 2021;14(4):828-834. doi:10.31362/patd.843176
Chicago
Koca Yozgat, Ayça, ve Selmin Karademir. 2021. “Clinical and prognostic factors in children with dilated cardiomyopathy”. Pamukkale Medical Journal 14 (4): 828-34. https://doi.org/10.31362/patd.843176.
EndNote
Koca Yozgat A, Karademir S (01 Ekim 2021) Clinical and prognostic factors in children with dilated cardiomyopathy. Pamukkale Medical Journal 14 4 828–834.
IEEE
[1]A. Koca Yozgat ve S. Karademir, “Clinical and prognostic factors in children with dilated cardiomyopathy”, Pam Tıp Derg, c. 14, sy 4, ss. 828–834, Eki. 2021, doi: 10.31362/patd.843176.
ISNAD
Koca Yozgat, Ayça - Karademir, Selmin. “Clinical and prognostic factors in children with dilated cardiomyopathy”. Pamukkale Medical Journal 14/4 (01 Ekim 2021): 828-834. https://doi.org/10.31362/patd.843176.
JAMA
1.Koca Yozgat A, Karademir S. Clinical and prognostic factors in children with dilated cardiomyopathy. Pam Tıp Derg. 2021;14:828–834.
MLA
Koca Yozgat, Ayça, ve Selmin Karademir. “Clinical and prognostic factors in children with dilated cardiomyopathy”. Pamukkale Medical Journal, c. 14, sy 4, Ekim 2021, ss. 828-34, doi:10.31362/patd.843176.
Vancouver
1.Ayça Koca Yozgat, Selmin Karademir. Clinical and prognostic factors in children with dilated cardiomyopathy. Pam Tıp Derg. 01 Ekim 2021;14(4):828-34. doi:10.31362/patd.843176